Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Pigs in farrowing crates and loose-housing systems showed no difference in chronic stress levels as measured by hair cortisol.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

First-time mothers had higher stress hormone levels in late pregnancy than mothers who had given birth before.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document concludes that more research is needed to fully understand the causes of PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.